You've slept well, but the mirror still makes you look tired. A groove beneath the inner corner of your eye catches the light, while a small hollow creates a shadow that concealer only partly hides. That's the situation that leads many adults to research under eye filler treatment, often called tear trough filler.
The important question isn't just which product to choose. It's whether the shadow comes from volume loss, pigment, fluid, lower-eyelid fat, skin laxity, or a combination of concerns. Under-eye filler can produce a subtle, refreshed result for the right anatomy, but the region has little room for technical error and complications can sometimes appear long after injection.
Table of Contents
- What Under Eye Filler Treats
- How Tear Trough Filler Works Under the Skin
- Fillers Used and How They Differ
- Why Placement and Injector Skill Matter Most
- Risks Most Articles Underplay
- What the Procedure and Recovery Look Like
- Cost, Longevity, and What Affects the Price
- Who Is a Good Candidate and Next Steps
What Under Eye Filler Treats
The tear trough is the groove where the lower eyelid transitions into the upper cheek. This junction includes thin skin, muscle, fat compartments, ligaments, blood vessels, and lymphatic channels. When the area has limited support or is naturally hollow, light falls into the groove and produces a tired-looking shadow, even after adequate sleep.
Under eye filler treatment targets that structural hollow. A soft gel can restore a small amount of volume and soften the lid-cheek transition. Filler improves shadowing caused by the groove itself; it does not remove brown pigment, correct every fine line, or tighten loose skin.
The concern must match the treatment
A lower-eyelid bag caused by protruding fat is different from a hollow tear trough. Adding filler beside a prominent fat pad can make the area look heavier or more swollen. Pigment-related darkness calls for a different strategy, such as appropriate skincare or a light-based treatment, rather than volume restoration alone.
The cheek also affects the plan. If volume loss extends below the trough, treating only the deepest part of the groove can create a visible step between the lower eyelid and cheek. A careful assessment considers whether the appropriate approach involves the trough, the cheek, both areas, or no filler.
The FDA approved Juvéderm Volbella XC on February 8, 2022, for injection into undereye hollows in adults over 21, with a cannula specified for the indication, as documented in the product's regulatory history (Juvéderm history and approval information). The approval established a formal indication for infraorbital hollowing. It does not make every patient a candidate.
Practical rule: A good consultation should explain what filler can improve, what it cannot improve, and how your anatomy changes the recommendation.
Good candidates generally have a genuine hollow, reasonable skin quality, realistic expectations, and no major fluid-retention problem or lower-lid laxity. The distinction between volume loss and muscle movement also matters when comparing filler with other aesthetic options, including those described in this guide to Botox and fillers.
How Tear Trough Filler Works Under the Skin
Tear trough filler doesn't work like a surface cream. The clinician aims to place a small amount of soft hyaluronic acid gel in a deeper plane, commonly beneath the orbicularis oculi muscle and close to the underlying bone. From that support point, the gel can gently support the hollow above it and reduce the shadow created by the lid-cheek contour.
That depth matters because the skin beneath the eye is thin and unforgiving. Product placed too close to the surface may become visible, feel uneven, or create a bluish cast known as a Tyndall effect. Product placed too aggressively can attract water, contribute to puffiness, or disrupt the natural transition between the eyelid and cheek.
Why hyaluronic acid is usually considered first
Hyaluronic acid has become the dominant material in published tear trough treatment experience. A 2021 systematic review analyzed 1,956 patients across 28 studies. Hyaluronic acid was used in 1,535 cases, or 78.5%, while calcium hydroxyapatite appeared in 376 cases, or 19.2% (systematic review of tear trough volumization).
The appeal isn't only familiarity. Hyaluronic acid gels can be selected for softness and flow, and clinicians can use hyaluronidase when dissolution is medically or aesthetically appropriate. That reversibility is useful, but it doesn't make correction effortless or guarantee that the original tissue appearance will return unchanged.
A structured deep injection approach, including the three-point tangent technique described in a 2023 clinical series, aims to distribute support rather than create a single conspicuous mound. The goal is a quiet improvement, not a visibly filled lower eyelid. Conservative volume, accurate depth, and patience during swelling are more important than chasing maximal correction at the first visit.
Fillers Used and How They Differ
The label “filler” describes a category, not one uniform material. Gels differ in softness, cross-linking, particle structure, water attraction, and how they spread through tissue. Those differences become highly visible beneath thin eyelid skin.
Hyaluronic acid is usually the starting category because clinicians can place it with precision and, when necessary, dissolve it with hyaluronidase. Juvéderm Volbella XC is the only product with a United States FDA indication specifically for infraorbital hollowing, according to the regulatory history cited earlier. Other hyaluronic acid products may be used off-label when their handling characteristics fit the patient's anatomy.
| Product category | Typical behavior | Longevity | Under-eye considerations |
|---|---|---|---|
| Soft hyaluronic acid | Supple, moldable, and suited to subtle support | Often measured in months rather than permanently | Frequently considered for thin skin, but water attraction and placement remain important |
| Firmer hyaluronic acid | Provides more structure and projection | Varies by formulation and patient | May be inappropriate if the gel is too visible or heavy for the eyelid |
| Calcium hydroxylapatite | Firmer support material | Behavior differs from soft gel fillers | Not reversible with hyaluronidase and generally demands caution in this sensitive region |
| Poly-L-lactic acid | Stimulates collagen rather than acting as a direct gel implant | Builds and changes differently from hyaluronic acid | Not a simple reversible option for the tear trough |
| Cheek-focused filler strategy | Supports the broader lid-cheek framework | Depends on the selected material | May be more appropriate when the hollow reflects loss of cheek support |
No product automatically solves poor candidacy or inaccurate placement. A softer gel can still cause edema when placed in a compartment that restricts drainage, while a firmer product can look natural in one facial structure and excessive in another.
People researching the available options through ProMD Health Columbia may also review RHA Fillers in Columbia, but a consultation should determine whether that category fits the under-eye region rather than treating a brand name as the decision.
Why Placement and Injector Skill Matter Most
The under-eye area is a map of boundaries, not an empty space waiting to be filled. The malar septum and orbicularis retaining ligament help define the lid-cheek junction, while nearby vessels and lymphatic pathways influence both safety and swelling. A clinician needs to identify where the hollow sits before deciding where, how slowly, and at what pace to inject.
Superficial placement above the orbicularis muscle can show through thin skin as a bluish discoloration or visible irregularity. Deeper placement isn't automatically harmless either. If filler sits in a space that restricts lymphatic drainage, the patient may develop prolonged malar swelling.
What the clinical data reveals
A 2023 series using the three-point tangent technique reported that 82% of patients had no complication after their first treatment. The same series recorded edema in 10%, with a median duration of 4 weeks and a range from 1 to 52 weeks. Bruising occurred in 4.3%, contour irregularities in 4.6%, and a Tyndall effect in 3.3% (2023 tear trough filler clinical series).
Those findings don't establish one technique as universally safe. They show why the plane and product position matter. An injector who understands the malar septum, retaining ligaments, vascular anatomy, and lymphatic drainage can make a more informed plan than someone who treats every under-eye hollow as a simple volume deficit.
Before consenting, ask:
- Relevant experience: How often does the clinician perform tear trough injections?
- Treatment plan: What makes you a candidate, and what concern won't filler address?
- Technique: Will the clinician use a needle, cannula, or a staged combination?
- Complication readiness: Is hyaluronidase available, and what is the urgent follow-up process?
- Restraint: Will the plan allow time for swelling to settle before adding more product?
The best result often looks like a rested version of you, not a filled version of you.
Risks Most Articles Underplay
Hyaluronic acid is dissolvable, but “dissolvable” doesn't mean “clean reset.” Hyaluronidase can reduce or remove product, yet the tissue may look hollow afterward, and persistent problems may require more than enzyme treatment.
A recent retrospective study of 54 patients with periorbital hyaluronic-acid complications found that persistent edema, tear-trough bulging, under-correction, and subcutaneous nodules were dominant presentations. After hyaluronidase, 64.8% ultimately required lower-eyelid blepharoplasty (retrospective review of periorbital filler complications).
Long-tail problems deserve a place in consent
Swelling can result from filler compressing lymphatic pathways near the malar septum. Late contour changes, nodules, visible blue discoloration, and migration can emerge after the initial result appeared acceptable. A rare vascular event can threaten the skin or vision, which is why urgent assessment matters when symptoms suggest compromised blood flow.
Hyaluronidase also has its own aesthetic downside. One study reported unwanted hollowing or other post-dissolution changes in 18% of patients, particularly when filler had remained in place longer or had been used in larger volume, as summarized in the complication literature linked above.
An ophthalmology reference reports that malar edema may occur in up to 11% of cases, and it also cites the 18% negative aesthetic outcome figure after hyaluronidase treatment (ophthalmology review of hyaluronic acid filler complications). These figures shouldn't be used to predict an individual result, but they do challenge the assumption that reversal is always simple.
The rare emergency
The tear trough overlies vessels including the angular artery and its branches. Vascular occlusion is considered the most dangerous filler complication in ophthalmology because product entering the retinal circulation can block blood flow and threaten vision (ophthalmology discussion of under-eye filler risks).
Urgent warning signs can include sudden severe pain, blanching or mottled skin, unusual visual symptoms, or rapidly changing color. Published vascular-occlusion guidance recommends immediate hyaluronidase treatment, including a protocol using 1,500 units infiltrated over the affected artery and ischemic area, with repeat treatment if capillary refill remains delayed beyond 3 seconds (published vascular-occlusion management guideline).
What the Procedure and Recovery Look Like
A sound appointment starts before the syringe enters the room. Tell the clinician about medications, supplements, allergies, prior filler, autoimmune conditions, eye disease, and any history of prolonged swelling. Avoiding alcohol and nonessential agents that increase bruising may be discussed, but don't stop prescribed medication without the prescribing clinician's advice.
Arrive with clean skin and little or no eye makeup. During the consultation, the clinician should assess the trough in different lighting, examine the lower-lid and cheek relationship, evaluate skin thickness and laxity, look for fluid retention, and ask what you want improved.
In the treatment room
The sequence commonly includes:
- Marking and planning: The clinician identifies the hollow, entry point, and boundaries where product should not be placed.
- Numbing: Local anesthetic or a topical numbing approach may reduce discomfort.
- Controlled access: A needle or blunt cannula creates the route for placement, depending on anatomy and technique.
- Layered correction: Small amounts are placed in a deep plane, with repeated reassessment rather than automatic use of a full syringe.
- Immediate inspection: The clinician checks symmetry and the lid-cheek transition without treating early swelling as the final result.
The under-eye region may look fuller immediately after injection because of product, fluid, and the body's response to the procedure. That first view isn't the final assessment.
Protecting the result afterward
For the initial recovery period, follow the treating clinician's specific instructions. Common precautions include sleeping with the head raised, avoiding pressure or rubbing, postponing strenuous exercise for 48 hours, and avoiding saunas or intense heat while swelling settles.
Bruising and edema can obscure the result early. Contact the clinic urgently for severe or escalating pain, skin blanching or mottling, new visual symptoms, or swelling that appears unusually one-sided or rapidly progressive. A routine follow-up is also valuable because subtle contour concerns are easier to assess after the initial inflammation has subsided.
Cost, Longevity, and What Affects the Price
A lower quote does not necessarily mean a simpler treatment. In Columbia, Maryland, hyaluronic acid tear trough filler may be quoted at $650 to $1,200 per syringe, but this is only a local planning estimate, not a guaranteed fee. The amount needed depends on your anatomy. One syringe may cover both sides, while broader cheek support may call for a staged plan and additional product.
Longevity also belongs in the cost discussion. Published long-term data on tear trough hyaluronic acid filler found an average initial augmentation of 0.21 cc per site, residual effect in 100% of treated tear troughs at final follow-up, and an average maintenance of effect of 85% after 14.4 months. These figures describe a study group, not a promise for every patient. Product choice, placement, metabolism, facial movement, swelling, and the accuracy of the original diagnosis can all change how long the result appears to last.
The fee reflects more than the syringe:
| Price factor | Typical impact | What it means for you |
|---|---|---|
| Injector credentials and experience | May raise the consultation or treatment fee | You're paying for anatomical judgment and complication management, not only product |
| Product selection | Different gels carry different costs | The least expensive option may not suit thin skin or edema-prone anatomy |
| Cannula or needle technique | Technique and setup can affect the fee | The method should follow anatomy and safety planning |
| Amount used | More product increases the treatment total | A conservative staged plan may be safer than correcting too much at once |
| Imaging and follow-up | Some practices include additional assessment or review | Ask what the quoted fee covers before comparing prices |
A staged plan can also affect total cost. Using less product at the first visit may leave room to reassess the contour after swelling settles, rather than paying for correction of an overfilled area later.
Before comparing prices, ask what the quote includes: consultation, product, injection, follow-up, and any assessment used for planning. Patients reviewing available options at ProMD Health Columbia can read about Juvéderm Fillers in Columbia and ask which product, amount, technique, and follow-up plan fit their anatomy.
Who Is a Good Candidate and Next Steps
The strongest candidate has a real tear trough hollow that creates shadowing, enough skin quality to support a subtle correction, and expectations centered on improvement rather than perfection. They understand that the lower eyelid is not a blank canvas and that treating a nearby cheek or skin-quality concern may be more appropriate than adding volume directly to the trough.
A clinician may recommend against immediate filler when prominent lower-eyelid fat pads, substantial skin laxity, persistent fluid retention, active dermatitis, uncontrolled thyroid eye disease, pregnancy, or a history of poor wound healing changes the risk-benefit balance. Prior filler, chronic swelling, and previous dissolving treatment also deserve careful review.
A practical candidacy checklist
You may be a reasonable candidate if:
- The problem is structural: Your main concern is a groove or hollow, not only pigment.
- The eyelid is stable: You don't have significant laxity, pronounced bags, or persistent malar swelling.
- Your expectations are measured: You want softer shadowing and a rested appearance, not complete erasure of every mark.
- You accept maintenance: The effect isn't permanent, and future decisions may include observation, retreatment, or correction.
- You're comfortable with uncertainty: Even careful treatment can involve swelling, bruising, asymmetry, or a result that requires reassessment.
If filler isn't the right first step, alternatives may include prescription skincare for surface concerns, energy-based skin tightening for selected texture or laxity concerns, neuromodulator treatment for certain expression-related lines, or lower blepharoplasty when fat pads and skin excess dominate. These options address different problems, so substitution should follow diagnosis rather than trend.
The 2025 real-world study cited in the medical literature reported more than 70% GAIS improvement for tear-trough and periorbital indications, 84.3% patient satisfaction, effects lasting up to 12 months, and mild or moderate adverse events that resolved within a month (2025 real-world tear trough filler study). Those findings support carefully selected treatment, not a universal recommendation. The same source discusses delayed chronic lower-eyelid edema, retreatment decisions, blepharoplasty, immune reactions, and biofilm-related concerns, reinforcing why timing and candidacy come before product selection.
ProMD Health Columbia offers clinician-guided consultations for under-eye filler in Columbia, Maryland, including assessment of tear trough anatomy, product planning, and discussion of potential outcomes. The Entity Med AI Simulator can help you preview possibilities, but it can't examine skin thickness, fluid movement, vascular anatomy, eyelid laxity, or medical history, so it can't replace an in-person evaluation.
If you're considering under eye filler treatment, schedule a consultation with ProMD Health Columbia to discuss whether your concern is caused by hollowing, pigment, bags, or skin laxity. The Columbia team can review your anatomy, explain product and technique choices, and help you choose a measured next step rather than committing to filler before you know it's appropriate.
